PRICES include / exclude VAT
Homepage>BS Standards>11 HEALTH CARE TECHNOLOGY>11.040 Medical equipment>11.040.40 Implants for surgery, prosthetics and orthotics>BS EN ISO 21535:2024 - TC Tracked Changes. Non-active surgical implants. Joint replacement implants. Specific requirements for hip-joint replacement implants
Sponsored link
immediate downloadReleased: 2024-09-20
BS EN ISO 21535:2024 - TC Tracked Changes. Non-active surgical implants. Joint replacement implants. Specific requirements for hip-joint replacement implants

BS EN ISO 21535:2024 - TC

Tracked Changes. Non-active surgical implants. Joint replacement implants. Specific requirements for hip-joint replacement implants

Format
Availability
Price and currency
English Secure PDF
Immediate download
438.02 EUR
English Hardcopy
In stock
438.02 EUR
Standard number:BS EN ISO 21535:2024 - TC
Pages:96
Released:2024-09-20
ISBN:978 0 539 33382 4
Status:Tracked Changes
DESCRIPTION

BS EN ISO 21535:2024 - TC


This standard BS EN ISO 21535:2024 - TC Tracked Changes. Non-active surgical implants. Joint replacement implants. Specific requirements for hip-joint replacement implants is classified in these ICS categories:
  • 11.040.40 Implants for surgery, prosthetics and orthotics
This document specifies requirements for hip-joint replacement implants. With regard to safety, this document specifies requirements for intended performance, design attributes, materials, design evaluation, manufacture, sterilization, packaging, information supplied by the manufacturer and methods of test. This document applies to both total and partial hip joint replacement implants. It applies to components made of metallic and non-metallic materials. This document applies to a wide variety of hip replacement implants, but for some specific hip replacement implant types, some considerations, not specifically covered in this document, can be applicable. Further details are given in 7.2.1.2. The requirements which are specified in this document are not intended to require the re-design or re-testing of implants which have been legally marketed and for which there is a history of sufficient and safe clinical use. For such implants, compliance with this document can be demonstrated by providing evidence of the implant’s sufficient and safe clinical use.